drugset / Trial / NCT06614608
The Safety and Pharmacokinetics of ASKC200 in Osteoarthritic Knee Pain
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multi-center, randomized, double-blind clinical trial to evaluate the safety, tolerability, pharmacokinetics, and efficacy of ASKC200 in subjects with OA of the knees and determine the phase II recommended dose. Assigned doses will be applied for 60 minutes on each of four consecutive days.
Timeline
- Start
- 2024-10
- Primary completion
- 2025-04
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capsaicin | Small molecule | 1 % | Topical |
| Subject | Capsaicin | Small molecule | 5 % | Topical |